Stockreport

Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors

ADVANCED ACCELERATOR APPLICATIONS SA AMERICAN DE  (AAAP) 
Last advanced accelerator applications sa american de earnings: 8/31 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: adacap.com/investor-relations
PDF First-in-class Therapy Demonstrated 79% Improvement in Progression Free Survival in NETTER-1 Phase 3 Study in Midgut NET Patients [Read more]